NCT00700544View on ClinicalTrials.gov

Treatment Outcome in Elderly Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

April 30, 2005

Study Completion Date

May 31, 2008

Conditions
AMLElderly Patients
Interventions
DRUG

chemotherapy treatment (see arm) + norethandrolone

"oral form~Dosage:~10 mg in patients with a weight \< 60 kgs 20 mg in patients with a weight \> 60 kgs frequency: every day Duration: 2 years"

DRUG

chemotherapy treatment (see arms)

Induction chemotherapy + maintenance chemotherapy

Trial Locations (1)

33604

Arnaud PIGNEUX, Pessac

All Listed Sponsors
collaborator

French Innovative Leukemia Organisation

OTHER

collaborator

BGMT

UNKNOWN

lead

University Hospital, Grenoble

OTHER

NCT00700544 - Treatment Outcome in Elderly Patients | Biotech Hunter | Biotech Hunter